175 related articles for article (PubMed ID: 25889974)
1. Correlations between immune response and vascularization qRT-PCR gene expression clusters in squamous cervical cancer.
Punt S; Houwing-Duistermaat JJ; Schulkens IA; Thijssen VL; Osse EM; de Kroon CD; Griffioen AW; Fleuren GJ; Gorter A; Jordanova ES
Mol Cancer; 2015 Mar; 14():71. PubMed ID: 25889974
[TBL] [Abstract][Full Text] [Related]
2. FoxP3(+) and IL-17(+) cells are correlated with improved prognosis in cervical adenocarcinoma.
Punt S; van Vliet ME; Spaans VM; de Kroon CD; Fleuren GJ; Gorter A; Jordanova ES
Cancer Immunol Immunother; 2015 Jun; 64(6):745-53. PubMed ID: 25795131
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer.
Tosolini M; Kirilovsky A; Mlecnik B; Fredriksen T; Mauger S; Bindea G; Berger A; Bruneval P; Fridman WH; Pagès F; Galon J
Cancer Res; 2011 Feb; 71(4):1263-71. PubMed ID: 21303976
[TBL] [Abstract][Full Text] [Related]
4. Tumor-infiltrating CD14-positive myeloid cells and CD8-positive T-cells prolong survival in patients with cervical carcinoma.
de Vos van Steenwijk PJ; Ramwadhdoebe TH; Goedemans R; Doorduijn EM; van Ham JJ; Gorter A; van Hall T; Kuijjer ML; van Poelgeest MI; van der Burg SH; Jordanova ES
Int J Cancer; 2013 Dec; 133(12):2884-94. PubMed ID: 23740735
[TBL] [Abstract][Full Text] [Related]
5. Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?
Jordanova ES; Gorter A; Ayachi O; Prins F; Durrant LG; Kenter GG; van der Burg SH; Fleuren GJ
Clin Cancer Res; 2008 Apr; 14(7):2028-35. PubMed ID: 18381941
[TBL] [Abstract][Full Text] [Related]
6. Multi-dose parecoxib provides an immunoprotective effect by balancing T helper 1 (Th1), Th2, Th17 and regulatory T cytokines following laparoscopy in patients with cervical cancer.
Ma W; Wang K; Du J; Luan J; Lou G
Mol Med Rep; 2015 Apr; 11(4):2999-3008. PubMed ID: 25434365
[TBL] [Abstract][Full Text] [Related]
7. Macrophage infiltration and angiogenesis in cervical squamous cell carcinoma--clinicopathologic correlation.
Davidson B; Goldberg I; Gotlieb WH; Lerner-Geva L; Ben-Baruch G; Agulansky L; Novikov I; Kopolovic J
Acta Obstet Gynecol Scand; 1999 Mar; 78(3):240-4. PubMed ID: 10078587
[TBL] [Abstract][Full Text] [Related]
8. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
[TBL] [Abstract][Full Text] [Related]
9. Investigations on the clinical significance of FOXP3 protein expression in cervical oesophageal cancer and the number of FOXP3+ tumour-infiltrating lymphocytes.
Xia M; Zhao MQ; Wu K; Lin XY; Liu Y; Qin YJ
J Int Med Res; 2013 Aug; 41(4):1002-8. PubMed ID: 23760912
[TBL] [Abstract][Full Text] [Related]
10. Immune stromal features in cervical squamous cell carcinoma are prognostic factors for distant metastasis: A retrospective study.
Cao L; Sun PL; He Y; Yao M; Gao H
Pathol Res Pract; 2020 Mar; 216(3):152751. PubMed ID: 31776057
[TBL] [Abstract][Full Text] [Related]
11. Local immune response in cutaneous basal cell carcinoma.
Omland SH
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975891
[TBL] [Abstract][Full Text] [Related]
12. Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma.
Richendollar BG; Pohlman B; Elson P; Hsi ED
Hum Pathol; 2011 Apr; 42(4):552-7. PubMed ID: 21237493
[TBL] [Abstract][Full Text] [Related]
13. High and interrelated rates of PD-L1+CD14+ antigen-presenting cells and regulatory T cells mark the microenvironment of metastatic lymph nodes from patients with cervical cancer.
Heeren AM; Koster BD; Samuels S; Ferns DM; Chondronasiou D; Kenter GG; Jordanova ES; de Gruijl TD
Cancer Immunol Res; 2015 Jan; 3(1):48-58. PubMed ID: 25361854
[TBL] [Abstract][Full Text] [Related]
14. Stromal Fibroblasts Induce CCL20 through IL6/C/EBPβ to Support the Recruitment of Th17 Cells during Cervical Cancer Progression.
Walch-Rückheim B; Mavrova R; Henning M; Vicinus B; Kim YJ; Bohle RM; Juhasz-Böss I; Solomayer EF; Smola S
Cancer Res; 2015 Dec; 75(24):5248-59. PubMed ID: 26631268
[TBL] [Abstract][Full Text] [Related]
15. Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinoma.
Yang CY; Lin MW; Chang YL; Wu CT; Yang PC
Eur J Cancer; 2016 Apr; 57():91-103. PubMed ID: 26901614
[TBL] [Abstract][Full Text] [Related]
16. PlGF expression in pre-invasive and invasive lesions of uterine cervix is associated with angiogenesis and lymphangiogenesis.
Yang S; Cheng H; Cai J; Cai L; Zhang J; Wang Z
APMIS; 2009 Nov; 117(11):831-8. PubMed ID: 19845534
[TBL] [Abstract][Full Text] [Related]
17. Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area.
Heeren AM; de Boer E; Bleeker MC; Musters RJ; Buist MR; Kenter GG; de Gruijl TD; Jordanova ES
Oncotarget; 2015 Oct; 6(32):32484-93. PubMed ID: 26431490
[TBL] [Abstract][Full Text] [Related]
18. A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17(+) cell frequency.
Punt S; Dronkers EA; Welters MJ; Goedemans R; Koljenović S; Bloemena E; Snijders PJ; Gorter A; van der Burg SH; Baatenburg de Jong RJ; Jordanova ES
Cancer Immunol Immunother; 2016 Apr; 65(4):393-403. PubMed ID: 26899388
[TBL] [Abstract][Full Text] [Related]
19. Whole-transcriptome analysis of flow-sorted cervical cancer samples reveals that B cell expressed TCL1A is correlated with improved survival.
Punt S; Corver WE; van der Zeeuw SA; Kielbasa SM; Osse EM; Buermans HP; de Kroon CD; Jordanova ES; Gorter A
Oncotarget; 2015 Nov; 6(36):38681-94. PubMed ID: 26299617
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD3-zeta on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes.
de Gruijl TD; Bontkes HJ; Peccatori F; Gallee MP; Helmerhorst TJ; Verheijen RH; Aarbiou J; Mulder WM; Walboomers JM; Meijer CJ; van de Vange N; Scheper RJ
Br J Cancer; 1999 Mar; 79(7-8):1127-32. PubMed ID: 10098746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
